EA201690123A1 - Сульфатированный полисахарид полигулоновой кислоты или фармацевтическая соль, способ получения и применение - Google Patents

Сульфатированный полисахарид полигулоновой кислоты или фармацевтическая соль, способ получения и применение

Info

Publication number
EA201690123A1
EA201690123A1 EA201690123A EA201690123A EA201690123A1 EA 201690123 A1 EA201690123 A1 EA 201690123A1 EA 201690123 A EA201690123 A EA 201690123A EA 201690123 A EA201690123 A EA 201690123A EA 201690123 A1 EA201690123 A1 EA 201690123A1
Authority
EA
Eurasian Patent Office
Prior art keywords
inhibitors
polygula
obtaining
acid
pharmaceutical salt
Prior art date
Application number
EA201690123A
Other languages
English (en)
Other versions
EA028655B1 (ru
Inventor
Цзянь Дин
Цзин Ай
И Чэнь
Сюнь Хуан
Original Assignee
Шангхай Инститьют Оф Матириа Медика Чайниз Акэдеми Оф Сайнсиз
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Шангхай Инститьют Оф Матириа Медика Чайниз Акэдеми Оф Сайнсиз filed Critical Шангхай Инститьют Оф Матириа Медика Чайниз Акэдеми Оф Сайнсиз
Publication of EA201690123A1 publication Critical patent/EA201690123A1/ru
Publication of EA028655B1 publication Critical patent/EA028655B1/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0084—Guluromannuronans, e.g. alginic acid, i.e. D-mannuronic acid and D-guluronic acid units linked with alternating alpha- and beta-1,4-glycosidic bonds; Derivatives thereof, e.g. alginates
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Materials Engineering (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Neurology (AREA)
  • Pulmonology (AREA)
  • Endocrinology (AREA)
  • Neurosurgery (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

Раскрываются сульфат полигулоновой кислоты или фармацевтически приемлемая соль, способ получения и использование в качестве ингибиторов роста и/или метастазирования опухолей. Сульфат полигулоновой кислоты или фармацевтически приемлемая соль настоящего изобретения могут использоваться в качестве любого одного или более из числа ингибиторов роста опухолей, ингибиторов метастазирования опухоли, ингибиторов ангиогенеза, ингибиторов гепараназы, ингибиторов C-Met фермента, ингибиторов полимеризации микротрубочек, ингибиторов активности факторов деполимеризации актина и/или ингибиторов агрегации актина.
EA201690123A 2013-07-02 2014-07-02 Сульфатированный полисахарид полигулоновой кислоты или фармацевтическая соль, способ получения и применение EA028655B1 (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201310275323.7 2013-07-02
CN201310275323.7A CN104277130A (zh) 2013-07-02 2013-07-02 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
PCT/CN2014/081472 WO2015000411A1 (zh) 2013-07-02 2014-07-02 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途

Publications (2)

Publication Number Publication Date
EA201690123A1 true EA201690123A1 (ru) 2016-07-29
EA028655B1 EA028655B1 (ru) 2017-12-29

Family

ID=52143111

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201690123A EA028655B1 (ru) 2013-07-02 2014-07-02 Сульфатированный полисахарид полигулоновой кислоты или фармацевтическая соль, способ получения и применение

Country Status (20)

Country Link
US (1) US10058566B2 (ru)
EP (1) EP3018147B1 (ru)
JP (2) JP6757249B2 (ru)
KR (1) KR102258569B1 (ru)
CN (2) CN104277130A (ru)
AU (1) AU2014286711B2 (ru)
BR (1) BR112015032849B1 (ru)
CA (1) CA2916749C (ru)
DK (1) DK3018147T3 (ru)
EA (1) EA028655B1 (ru)
ES (1) ES2674976T3 (ru)
HK (1) HK1220984A1 (ru)
HU (1) HUE038981T2 (ru)
MX (1) MX2016000043A (ru)
PL (1) PL3018147T3 (ru)
PT (1) PT3018147T (ru)
SG (1) SG11201510717SA (ru)
TR (1) TR201809674T4 (ru)
WO (1) WO2015000411A1 (ru)
ZA (1) ZA201509353B (ru)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104277130A (zh) * 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途
CN107904240A (zh) * 2017-12-04 2018-04-13 辽东学院 一种抗肝癌细胞转移的抑制剂组合物

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3228231A1 (de) 1982-07-28 1984-02-02 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V., 8000 München Arzneimittel, calciummischsalze von polymeren, anionischen carbonsaeuren und/oder schwefelsaeureestern, verfahren zu ihrer herstellung und ihre verwendung
JPH0625304A (ja) 1992-07-06 1994-02-01 Higeta Shoyu Co Ltd ガラクトサミン重合体硫酸化物及び該物質を 含有する抗ウイルス剤
CN1132209A (zh) * 1995-03-27 1996-10-02 青岛海洋大学 一种新药多聚甘露糖醛酸硫酸盐
GB2317182B (en) 1996-09-11 2000-11-01 Johnson & Johnson Medical Sulfated polysaccharides and uses thereof in medical treatment
CN1473836A (zh) 2003-08-04 2004-02-11 中国海洋大学 还原端1位为羧基的古罗糖醛酸寡糖及其衍生物
CN1213071C (zh) * 2003-11-25 2005-08-03 中国海洋大学 一种古糖酯及其制备方法和应用
JP4897310B2 (ja) 2006-02-28 2012-03-14 理研食品株式会社 Ｌ−グルロン酸金属塩又はｄ−マンヌロン酸金属塩の製造方法
JP2008027767A (ja) 2006-07-21 2008-02-07 Aomori Prefecture 固体高分子電解質膜及び燃料電池
CN101691410B (zh) * 2009-09-18 2011-12-28 中国海洋大学 一种具有防治胰岛素抵抗作用的海洋寡糖铬配合物
CA2791418C (en) 2010-03-10 2016-07-05 Inovobiologic, Inc. Food comprising glucomannan, xanthan gum and alginate for the treatment of metabolic disorders
CN102743409B (zh) * 2012-06-18 2013-11-20 中国海洋大学 聚甘露糖醛酸丙酯硫酸盐在制备抗甲型h1n1流感病毒药物中的应用
CN104277130A (zh) * 2013-07-02 2015-01-14 中国科学院上海药物研究所 一种硫酸酯化聚古洛糖酸多糖或其可药用盐及其制备方法和用途

Also Published As

Publication number Publication date
JP6772318B2 (ja) 2020-10-21
WO2015000411A1 (zh) 2015-01-08
ES2674976T3 (es) 2018-07-05
ZA201509353B (en) 2017-08-30
HK1220984A1 (zh) 2017-05-19
TR201809674T4 (tr) 2018-07-23
AU2014286711B2 (en) 2018-05-10
JP2016523301A (ja) 2016-08-08
EP3018147A4 (en) 2017-04-05
CN104277130A (zh) 2015-01-14
AU2014286711A1 (en) 2016-02-04
EP3018147A1 (en) 2016-05-11
US20160367591A1 (en) 2016-12-22
MX2016000043A (es) 2016-05-31
CA2916749C (en) 2021-03-09
CN105358582B (zh) 2018-09-21
EP3018147B1 (en) 2018-05-23
JP6757249B2 (ja) 2020-09-16
KR20160029817A (ko) 2016-03-15
BR112015032849B1 (pt) 2021-09-14
CN105358582A (zh) 2016-02-24
JP2019090056A (ja) 2019-06-13
US10058566B2 (en) 2018-08-28
PT3018147T (pt) 2018-07-17
SG11201510717SA (en) 2016-01-28
DK3018147T3 (en) 2018-07-23
PL3018147T3 (pl) 2018-10-31
CA2916749A1 (en) 2015-01-08
KR102258569B1 (ko) 2021-05-28
BR112015032849A2 (pt) 2020-05-12
HUE038981T2 (hu) 2018-12-28
EA028655B1 (ru) 2017-12-29

Similar Documents

Publication Publication Date Title
EA201890126A1 (ru) Новые бициклические производные, способ их получения и фармацевтические композиции, содержащие их
EA201691988A1 (ru) Производные бороновой кислоты и их терапевтическое применение
EA201691582A1 (ru) Новые фармацевтические препараты
MX2017006266A (es) Compuestos de heteroarilo como inhibidores de cinasas asociadas al receptor de interleucina 1(irak) y sus usos.
EA201692425A1 (ru) Модифицированные биополимеры и способы их получения и использования
TN2015000519A1 (en) Small molecule inhibitors of fibrosis
EA201790785A1 (ru) Производные тетрагидроизохинолина
MX2017008386A (es) Administración específica del sitio de un inhibidor de btk.
BR112017018620A2 (pt) método de administração de tradipitanto, e, tradipitanto.
EA202091397A1 (ru) Бензохинолоновые ингибиторы vmat2
EA201691918A1 (ru) Фармацевтические составы ингибитора киназ семейства raf, способы их получения и способы их применения
EA201500931A1 (ru) Производные пиридин-4-ила
EA201890442A1 (ru) Получение фоторецепторов для лечения заболеваний сетчатки
BR112017000730B8 (pt) Derivados de pirrolidinona como inibidores de metap-2, e medicamentos
WO2014153495A3 (en) Novel stat3 inhibitors
MY193444A (en) Cell-free production of ribonucleic acid
BR112015031417A8 (pt) forma de dosagem farmacêutica, composição farmacêutica, métodos para tratamento de um paciente com necessidade de cisteamina e para preparo de uma forma de dosagem
SA517381678B1 (ar) مركبات داي هيدرو بيريميدين-2-أون واستخدامها الطبي
EA201992832A1 (ru) Подкожное введение adamts13
BR112018001942A2 (pt) ?novo uso de sulfato de dextrano?
EA201692518A3 (ru) Способы улучшения производительности миокарда у пациентов после операции фонтена с применением композиций уденафила
EA201700356A1 (ru) Новые циклопропанбензофуранилпиридопиразиндионы
UY34543A (es) Derivados de sulfonilaminopirrolidinona, su preparación y aplicación terapéutica.
EA201791645A1 (ru) Новые соли и полиморфы scy-078
JOP20190163B1 (ar) منشط nrf2